Clinical Trials Logo

Clinical Trial Summary

This study's main specific aims are; 1. To develop robust acquisition and reconstruction methods specifically for the study of microvascular cardiac remodeling with MRI which will include very innovative quantitative perfusion methods, as well as fibrosis quantification, longitudinal strain, and phase contrast imaging for flow. 2. Test the new methods for identifying the clinical task of characterizing HFpEF.


Clinical Trial Description

Heart failure with preserved ejection fraction (HFpEF) is currently being studied intensely as several large trials of drug therapies have failed to benefit patients. Better characterization of these patients is important, and there are open questions regarding microvascular disease and remodeling in the HFpEF population. New MRI methods could be ideal to better characterize and understand HFpEF and its response to treatments. This project seeks to develop, evaluate and apply new MRI methods for high-end perfusion imaging. These methods will estimate endo/epi ratios across the cardiac cycle in free-breathing studies, which will provide new information about microvascular disease. This is of particular value for assessing HFpEF. The idea of this project is to combine new techniques for quantitative cardiac perfusion MRI imaging that would be ideally suited for answering open questions regarding HFpEF and for studying microvascular disease. The methods could potentially also predict patients who might respond to particular drug therapies. The new techniques include "simultaneous multi-slice" imaging which has not been used this way for myocardial perfusion imaging. In particular, we are developing an innovative hybrid of the standard saturation pulse and steady state spoiled gradient echo acquisitions. We also are developing a new method for using 3D "stack of stars" + 2D slice in the same scan for arterial input function assessment to quantify perfusion, and new methods for measuring T1. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04600115
Study type Interventional
Source University of Utah
Contact Nousheen Alasti, BS
Phone 801-585-6142
Email Nousheen.alasti@hsc.utah.edu
Status Recruiting
Phase Early Phase 1
Start date March 3, 2017
Completion date March 3, 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT02608944 - Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging N/A
Completed NCT04448600 - Bone Conduction Implant and MRI
Recruiting NCT03891511 - TMJ Fibrocartilage Detection Using MRI
Not yet recruiting NCT04871555 - Structural Cartography of the Insula in Temporal Epilepsy Patients
Completed NCT02318550 - Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD
Recruiting NCT04171635 - Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy